Technical Description
Alzheimer’s disease (AD) is a neurodegenerative disease that slowly destroys memory and thinking skills, and eventually affects even the ability to carry out the simplest tasks. The present invention relates to Acetylcholinesterase (Ache) inhibitors coated nanoparticle conjugates for the treatment of neurodegenerative disorders such as Alzheimer’s disease.
Tech Features
- Low dose administration
- Enhanced bioavailability
- Longer Stability
- Longer half-life
- Minimal side effects
Target Audience
- Healthcare facilities, Hospitals
- Alzheimer’s disease patient centred care
- Pharma Industry
- Research & Development Sector
Tech ID: P26-1029 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
